Discover
AKTS
Aktis Oncology, Inc.
24.63
5 x 24.63
1 x 24.67
bid
ask
+
0.00
0.00%
1 @ 04:00 PM
23.60 -1.03 (4.18%)
| Ytd | 66109.68% | |
| 1y | 66109.68% |
day range
14.72
52 week range
34.19
| Open | Prev Close | 24.63 | Low | High | Mkt Cap | 1.32B | |||
| Vol | 0.00 | Avg Vol | 347.06K | EPS | -18.57 | P/E | -1.33 | Forward P/E | -14.39 |
| Beta | N/A | Short Ratio | 7.27 | Inst. Own | 74.28% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-11 | 50-d Avg | 23.19 | 200-d Avg | 20.74 | 1yr Est | 33.88 |
| Income Statement | |||
| Total Revenue | 3.23M | ||
| Revenues (USD) | 3.23M | ||
| Gross Profit | 3.23M | ||
| Operating Expenses | 25.93M | ||
| Research and Development Expense | 20.04M | ||
| Selling, General and Administrative Expense | 5.90M | ||
| Operating Income | -22.71M | ||
| Net Income | -18.32M | ||
| Net Income Common Stock | -18.32M | ||
| Net Income Common Stock (USD) | -18.32M | ||
| Consolidated Income | -18.32M | ||
| Earnings per Basic Share | -0.38 | ||
| Earnings per Basic Share (USD) | -0.38 | ||
| Earnings per Diluted Share | -0.38 | ||
| Earning Before Interest & Taxes (EBIT) | -18.32M | ||
| Earning Before Interest & Taxes (USD) | -18.32M | ||
| Weighted Average Shares | 48.63M | ||
| Weighted Average Shares Diluted | 48.63M | ||
| Balance Sheet | |||
| Cash and Equivalents | 372.78M | ||
| Cash and Equivalents (USD) | 372.78M | ||
| Investments | 166.85M | ||
| Investments Current | 166.85M | ||
| Current Assets | 543.94M | ||
| Property, Plant & Equipment Net | 28.11M | ||
| Total Assets | 576.80M | ||
| Debt Current | 1.43M | ||
| Total Debt | 11.58M | ||
| Current Liabilities | 27.91M | ||
| Debt Non-Current | 10.15M | ||
| Total Liabilities | 70.69M | ||
| Accumulated Retained Earnings (Deficit) | -174.89M | ||
| Accumulated Other Comprehensive Income | -241.00K | ||
| Shareholders Equity | 506.11M | ||
| Shareholders Equity (USD) | 506.11M | ||
| Assets Non-Current | 32.86M | ||
| Total Debt (USD) | 11.58M | ||
| Deferred Revenue | 51.59M | ||
| Liabilities Non-Current | 42.78M | ||
| Trade and Non-Trade Payables | 1.23M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 652.00K | ||
| Net Cash Flow from Financing | 337.55M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 333.85M | ||
| Capital Expenditure | -1.85M | ||
| Issuance (Purchase) of Equity Shares | 339.81M | ||
| Net Cash Flow from Investing | 20.54M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 22.40M | ||
| Net Cash Flow from Operations | -24.24M | ||
| Share Based Compensation | 3.02M | ||